Cenduit LLC to Showcase Market-Leading IRT at DIA China 2019


Learn how Cenduit IRT technology and services enable study sponsors to significantly improve the quality, safety and economics of clinical trials at DIA exhibit booth #M02

May 17, 2019– Durham, NC – At DIA China, Booth #M02, May 20-23 in Beijing, Cenduit LLC will continue to define innovation in IRT (Interactive Response Technology) and eClinical technologies as it demonstrates the latest innovations within its Cenduit IRT (CIRT) platform for efficient, safe and economical clinical trials. Cenduit continues to achieve robust growth in the Asia-Pacific region, supported by operations in Bangalore, Tokyo, and Shanghai, as more study sponsors adopt its digitized, integrated technology systems to generate measurable scientific and economic efficiencies for patient outcomes.

Cenduit executives in attendance will include Jinu Jose, Vice President of Operations along with other subject matter experts in Cenduit’s IRT and eClinical solutions. (Read Jinu Jose’s Pharma Tech Outlook magazine article, “Industrializing Operational Excellence through Quality, Innovation and Expertise,” here.)

To arrange a demonstration and meeting with Cenduit executives attending DIA China, contact us here.

About Cenduit LLC

Cenduit enables clinical study sponsors and CROs to safely, quickly and economically deliver new drugs and therapies that improve and save lives. As the world leader in quality IRT systems, Cenduit accelerates study startup, with clinical supply chain intelligence, deep clinical operations expertise and client-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps clients manage clinical studies in over 100 countries, interacting with over 1,000,000 patients at nearly 33,000 sites. Visit www.cenduit.com for more information.


Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393

Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253